Page 58 - Read Online
P. 58

imaging (MRI) can be used to evaluate inflammation and   Fukuhara S, Hashimoto N, Nakayama    T, Sakai M, Teramoto A,
           destabilization of the CA wall by utilizing ferumoxytol   Tominari  S,  Yoshimoto  T.  The  natural  course  of  unruptured
           uptake as a surrogate indicator of macrophage turnover.   cerebral  aneurysms  in  a  Japanese  cohort.  N  Engl  J  Med
                                                                  2012;366:2474‑82.
           More recently, Edjlali et al.  found that circumferential   7.   Naggara ON, Lecler A, Oppenheim C, Meder JF, Raymond J.
                                 [18]
           enhancement of the CA wall on MRI can identify CAs     Endovascular treatment of intracranial unruptured aneurysms:
           prone to rupture. Although our knowledge of CA         a systematic review of the literature on safety with emphasis on
           pathobiology has improved significantly over the   8.   subgroup analyses. Radiology 2012;263:828‑35.
                                                                  Kotowski  M, Naggara  O, Darsaut  TE, Nolet  S, Gevry  G,
           past decade, there remains much to be learned and      Kouznetsov E, Raymond J. Safety and occlusion rates of surgical
           tested. One challenge in determining the role of the   treatment of unruptured intracranial aneurysms: a systematic review
           immune system in CA pathogenesis is the phenotypic     and meta‑analysis of the literature from 1990 to 2011. J Neurol
           plasticity exhibited by SMCs, a unique phenomenon   9.   Neurosurg Psychiatry 2013;84:42‑8.
                                                                  Starke RM, Durst CR, Evans A, Ding D, Raper DM, Jensen ME,
           not observed in cardiac and skeletal muscle cells.     Crowley  RW,  Liu  KC.  Endovascular  treatment  of  unruptured
           In the setting of vascular injury or inflammation,     wide‑necked intracranial aneurysms: comparison of dual
           SMCs undergo phenotypic modulation, a process by       microcatheter  technique  and  stent‑assisted  coil  embolization.
                                                                  J Neurointerv Surg 2015;7:256‑61.
           which markers of mature SMCs are downregulated and   10.  Starke RM, Turk A, Ding D, Crowley RW, Liu KC, Chalouhi N,
           markers of inflammatory cells, such as macrophages,    Hasan DM, Dumont AS, Jabbour P, Durst CR, Turner RD. Technology
           are upregulated. [19]  Given the inability of conventional   developments in endovascular treatment of intracranial aneurysms.
           immunohistochemical staining methods to identify       J Neurointerv Surg 2014. [DOI: 10.1136/neurintsurg‑2014‑011475].
           transdifferentiated SMCs, evaluation of SMC epigenetic   11.  Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG,
                                                                  Huston J, Capuano AW, Torner JC. Aspirin as a promising agent
           signatures  and  SMC  lineage  tracing  studies  are   for decreasing incidence of cerebral aneurysm rupture. Stroke
           necessary to accurately assess the contribution of     2011;42:3156‑62.
           SMCs to vascular lesions, such as CAs. [20]  Thus, the   12.  Nuki  Y, Tsou  TL, Kurihara  C, Kanematsu  M, Kanematsu  Y,
           respective roles of cells of SMC and myeloid lineage   Hashimoto  T. Elastase‑induced intracranial aneurysms in
                                                                  hypertensive mice. Hypertension 2009;54:1337‑44.
           in CA formation, progression, and rupture remains   13.  Starke RM, Raper DM, Ding D, Chalouhi N, Owens GK, Hasan DM,
           incompletely defined. [21]                             Medel R, Dumont AS. Tumor necrosis factor‑α modulates cerebral
                                                                  aneurysm formation and rupture. Transl Stroke Res 2014;5:269‑77.
           Despite the current limitations in our understanding   14.  Peña‑Silva RA, Chalouhi N, Wegman‑Points L, Ali M, Mitchell I,
                                                                  Pierce GL, Chu Y, Ballas ZK, Heistad D, Hasan D. Novel role
           of CA pathogenesis, the future of CA translational     for endogenous hepatocyte growth factor in the pathogenesis of
           and clinical research is promising. In this special    intracranial aneurysms. Hypertension 2015;65:587‑93.
           issue of Neuroimmunology and Neuroinflammation     15.  Peña Silva  RA, Kung  DK, Mitchell  IJ, Alenina  N, Bader  M,
           on the topic of “The Role of Inflammation in Cerebral   Santos RA, Faraci FM, Heistad DD, Hasan DM. Angiotensin 1‑7
                                                                  reduces mortality and rupture of intracranial aneurysms in mice.
           Aneurysms”, we have assembled a collection of articles   Hypertension 2014;64:362‑8.
           from renowned experts in the field of cerebrovascular   16.  Starke RM, Chalouhi N, Jabbour PM, Tjoumakaris SI, Gonzalez LF,
           disease, and attempt to lift the veil on the pathobiology   Rosenwasser RH, Wada K, Shimada K, Hasan DM, Greig NH,
           of intracranial aneurysms.                             Owens GK, Dumont AS. Critical role of TNF‑α in cerebral aneurysm
                                                                  formation and progression to rupture.  J  Neuroinflammation
                                                                  2014;11:77.
           REFERENCES                                         17.  Hasan  D, Chalouhi  N, Jabbour  P, Dumont  AS, Kung  DK,
                                                                  Magnotta VA, Young WL, Hashimoto T, Winn HR, Heistad D. Early
           1.   Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms:   change in ferumoxytol‑enhanced magnetic resonance imaging signal
              epidemiology, natural history, management options, and familial   suggests unstable human cerebral aneurysm: a pilot study. Stroke
              screening. Lancet Neurol 2014;13:393‑404.           2012;43:3258‑65.
           2.   Hop JW, Rinkel GJ, Algra A, van Gijn J. Case‑fatality rates and   18.  Edjlali M, Gentric JC, Régent‑Rodriguez C, Trystram D, Hassen WB,
              functional outcome after subarachnoid hemorrhage: a systematic   Lion  S,  Nataf  F,  Raymond  J,  Wieben  O,  Turski  P,  Meder  JF,
              review. Stroke 1997;28:660‑4.                       Oppenheim C, Naggara O. Does aneurysmal wall enhancement on
           3.   Mayer SA, Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S,   vessel wall MRI help to distinguish stable from unstable intracranial
              Claassen J, Du YE, Connolly ES Jr. Global and domain‑specific   aneurysms? Stroke 2014;45:3704‑6.
              cognitive impairment and outcome after subarachnoid hemorrhage.   19.  Owens GK. Regulation of differentiation of vascular smooth muscle
              Neurology 2002;59:1750‑8.                           cells. Physiol Rev 1995;75:487‑517.
           4.   Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ.   20.  Gomez D, Owens GK. Smooth muscle cell phenotypic switching in
              Changes in case fatality of aneurysmal subarachnoid haemorrhage   atherosclerosis. Cardiovasc Res 2012;95:156‑64.
              over time, according to age, sex, and region: a meta‑analysis. Lancet   21.  Starke RM, Chalouhi N, Ding D, Raper DM, Mckisic MS, Owens GK,
              Neurol 2009;8:635‑42.                               Hasan DM, Medel R, Dumont AS. Vascular smooth muscle cells in
           5.   Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr,   cerebral aneurysm pathogenesis. Transl Stroke Res 2014;5:338‑46.
              Piepgras DG, Forbes GS, Thielen K, Nichols D, O’Fallon WM,
              Peacock  J,  Jaeger  L,  Kassell  NF,  Kongable‑Beckman  GL,
              Torner JC; International Study of Unruptured Intracranial Aneurysms   Cite this article as: Ding D. Inflammation of the cerebral arteries: lifting
                                                               the  veil  on  the  pathobiology  of  intracranial  aneurysms.  Neuroimmunol
              Investigators. Unruptured intracranial aneurysms: natural history,   Neuroinflammation 2015;2(2):49-50.
              clinical outcome, and risks of surgical and endovascular treatment.
              Lancet 2003;362:103‑10.                          Source of Support: Nil. Conflict of Interest: No.
           6.   UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N,   Received: 19-01-2015; Accepted: 25-01-2015



            50                                               Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015
   53   54   55   56   57   58   59   60   61   62   63